HYPERPLASIA

This adverse event was reported 900 times

These drugs are most commonly taken by patients reporting HYPERPLASIA:

# Drug Count
0 METHOTREXATE SODIUM 68
1 METHOTREXATE 60
2 PREDNISONE 59
3 ADALIMUMAB 56
4 CYCLOSPORINE 55
5 MYCOPHENOLATE MOFETIL 51
6 AMLODIPINE 47
7 PREDNISOLONE 45
8 PREDNISOLONE ORAL 45
9 PREDNISOLONE ORAL SOLUTION 45
See all common drugs associated with HYPERPLASIA

HYPERPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GENTIAN VIOLET 1 0.0192
1 PHENAZOPYRIDINE HYDROCHLORIDE 4 0.0121
2 AMCINONIDE 1 0.0118
3 PENPULIMAB 1 0.0102
4 DESIPRAMINE HYDROCHLORIDE 1 0.0036
5 BORON 1 0.0033
6 SODIUM PHENYLBUTYRATE 1 0.0024
7 ADEFOVIR DIPIVOXIL 3 0.0024
8 HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE 1 0.0023
9 TOREMIFENE CITRATE 1 0.0023
See all drugs enriched for association with HYPERPLASIA

HYPERPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Tricyclic Antidepressant [EPC] 1 0.0021
1 Interleukin-5 Antagonist [EPC] 1 0.0015
2 Blood Viscosity Reducer [EPC] 6 0.0014
3 Estrogen Agonist/Antagonist [EPC] 3 0.0012
4 Calcitonin [EPC] 3 0.0010
5 Interleukin-1 Receptor Antagonist [EPC] 16 0.0009
6 Ergot Derivative [EPC] 4 0.0008
7 Leptin Analog [EPC] 1 0.0008
8 Photoenhancer [EPC] 3 0.0008
9 CD52-directed Cytolytic Antibody [EPC] 14 0.0007
See all drug classes enriched for association with HYPERPLASIA